Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter Annaert

Showing results (21-30 of 221) with videos related to

Pageof 23
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 27, 2013
Hepatobiliary and intestinal elimination of darunavir in an integrated preclinical rat modelJef Stappaerts, Sarinj Fattah, Pieter Annaert, et al.
Drug Metabolism Reviews|February 26, 2016
Clinical determinants of calcineurin inhibitor disposition: a mechanistic reviewThomas Vanhove, Pieter Annaert, Dirk R J Kuypers
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 11, 2018
MRP2 Inhibition by HIV Protease Inhibitors in Rat and Human Hepatocytes: A Quantitative Confocal Microscopy StudyNico Holmstock, Marlies Oorts, Jan Snoeys, et al.
International Journal of Pharmaceutics|December 3, 2014
In situ perfusion in rodents to explore intestinal drug absorption: challenges and opportunitiesJef Stappaerts, Joachim Brouwers, Pieter Annaert, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 17, 2025
Inhibition of ABC transporters by sorafenib and lenvatinib: implications for drug-induced cholestasisGetahun Befirdu Abza, Kristof De Vos, Pieter Annaert
Current Pharmaceutical Design|March 22, 2019
Non-clinical Models to Determine Drug Passage into Human Breast MilkDomenico Ventrella, Monica Forni, Maria Laura Bacci, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 7, 2022
Current and future physiologically based pharmacokinetic (PBPK) modeling approaches to optimize pharmacotherapy in preterm neonatesKarel Allegaert, Mohammad Yaseen Abbasi, Pieter Annaert, et al.
Frontiers in Pharmacology|June 2, 2020
A Physiology-Based Pharmacokinetic Framework to Support Drug Development and Dose Precision During Therapeutic Hypothermia in NeonatesAnne Smits, Pieter Annaert, Steven Van Cruchten, et al.
Biopharmaceutics & Drug Disposition|March 19, 2010
Interaction of eight HIV protease inhibitors with the canalicular efflux transporter ABCC2 (MRP2) in sandwich-cultured rat and human hepatocytesZhi-Wei Ye, Sandrine Camus, Patrick Augustijns, et al.
Journal of Pharmacological and Toxicological Methods|May 20, 2017
Integration and validation of the ex vivo human placenta perfusion modelSigrid Conings, Frédéric Amant, Pieter Annaert, et al.
Pageof 23

Showing results (21-30 of 221) with videos related to

Sort By:
Pageof 23
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 27, 2013
Hepatobiliary and intestinal elimination of darunavir in an integrated preclinical rat modelJef Stappaerts, Sarinj Fattah, Pieter Annaert, et al.
Drug Metabolism Reviews|February 26, 2016
Clinical determinants of calcineurin inhibitor disposition: a mechanistic reviewThomas Vanhove, Pieter Annaert, Dirk R J Kuypers
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 11, 2018
MRP2 Inhibition by HIV Protease Inhibitors in Rat and Human Hepatocytes: A Quantitative Confocal Microscopy StudyNico Holmstock, Marlies Oorts, Jan Snoeys, et al.
International Journal of Pharmaceutics|December 3, 2014
In situ perfusion in rodents to explore intestinal drug absorption: challenges and opportunitiesJef Stappaerts, Joachim Brouwers, Pieter Annaert, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 17, 2025
Inhibition of ABC transporters by sorafenib and lenvatinib: implications for drug-induced cholestasisGetahun Befirdu Abza, Kristof De Vos, Pieter Annaert
Current Pharmaceutical Design|March 22, 2019
Non-clinical Models to Determine Drug Passage into Human Breast MilkDomenico Ventrella, Monica Forni, Maria Laura Bacci, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 7, 2022
Current and future physiologically based pharmacokinetic (PBPK) modeling approaches to optimize pharmacotherapy in preterm neonatesKarel Allegaert, Mohammad Yaseen Abbasi, Pieter Annaert, et al.
Frontiers in Pharmacology|June 2, 2020
A Physiology-Based Pharmacokinetic Framework to Support Drug Development and Dose Precision During Therapeutic Hypothermia in NeonatesAnne Smits, Pieter Annaert, Steven Van Cruchten, et al.
Biopharmaceutics & Drug Disposition|March 19, 2010
Interaction of eight HIV protease inhibitors with the canalicular efflux transporter ABCC2 (MRP2) in sandwich-cultured rat and human hepatocytesZhi-Wei Ye, Sandrine Camus, Patrick Augustijns, et al.
Journal of Pharmacological and Toxicological Methods|May 20, 2017
Integration and validation of the ex vivo human placenta perfusion modelSigrid Conings, Frédéric Amant, Pieter Annaert, et al.
Pageof 23